Last reviewed · How we verify
Streptococcus pneumoniae
This is a bacterial pathogen, not a pharmaceutical drug—Streptococcus pneumoniae is a gram-positive bacterium that causes respiratory and invasive infections.
At a glance
| Generic name | Streptococcus pneumoniae |
|---|---|
| Also known as | Prevnar, PCV7 |
| Sponsor | Ohio State University Comprehensive Cancer Center |
| Modality | Biologic |
| Phase | FDA-approved |
Mechanism of action
Streptococcus pneumoniae is a naturally occurring pathogenic bacterium, not a manufactured therapeutic agent. It is the causative agent of pneumococcal diseases including pneumonia, meningitis, and bacteremia. The listing appears to be a data entry error, as bacterial pathogens are not drugs and are not developed by cancer centers as therapeutics.
Approved indications
Common side effects
Key clinical trials
- Streptococcus Pneumoniae Nasopharyngeal Carriage (NA)
- A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting Pneumonia
- Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs (PHASE4)
- Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'Ivoire (PHASE4)
- A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002) (PHASE1)
- Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective Endocarditis (PHASE3)
- Nasopharyngeal Carriage of S. Pneumoniae (NA)
- Bacteriological Evaluation of Children With Otorrhea
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Streptococcus pneumoniae CI brief — competitive landscape report
- Streptococcus pneumoniae updates RSS · CI watch RSS
- Ohio State University Comprehensive Cancer Center portfolio CI